|
RHBDD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.989600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.421390E-01 |
| Normal-vs-Stage2 |
1.732400E-01 |
| Normal-vs-Stage3 |
9.91969999999398E-05 |
| Normal-vs-Stage4 |
8.31880000440322E-08 |
| Stage1-vs-Stage2 |
5.544000E-01 |
| Stage1-vs-Stage3 |
1.619670E-03 |
| Stage1-vs-Stage4 |
1.68408999999814E-05 |
| Stage2-vs-Stage3 |
1.354840E-01 |
| Stage2-vs-Stage4 |
1.421900E-02 |
| Stage3-vs-Stage4 |
2.026000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.140200E-03 |
| Normal-vs-AfricanAmerican |
2.79800000002606E-06 |
| Normal-vs-Asian |
5.323200E-01 |
| Caucasian-vs-AfricanAmerican |
6.677500E-03 |
| Caucasian-vs-Asian |
7.406000E-01 |
| AfricanAmerican-vs-Asian |
1.322170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37069999999839E-05 |
| Normal-vs-Female |
1.191380E-01 |
| Male-vs-Female |
1.490460E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.058000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.017440E-03 |
| Normal-vs-Age(61-80Yrs) |
3.341100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.983600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.603380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.762380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.709790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.089200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.974200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.451600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.501000E-01 |
| Normal-vs-Grade 2 |
8.487600E-02 |
| Normal-vs-Grade 3 |
1.578000E-03 |
| Normal-vs-Grade 4 |
5.49649999959101E-08 |
| Grade 1-vs-Grade 2 |
6.825400E-01 |
| Grade 1-vs-Grade 3 |
3.467400E-01 |
| Grade 1-vs-Grade 4 |
1.294100E-02 |
| Grade 2-vs-Grade 3 |
8.906300E-02 |
| Grade 2-vs-Grade 4 |
2.49769999999261E-05 |
| Grade 3-vs-Grade 4 |
4.102100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.471400E-01 |
| Normal-vs-ccB subtype |
5.92419999999594E-05 |
| ccA subtype-vs-ccB subtype |
2.13409999999525E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.778300E-03 |
| Normal-vs-N1 |
1.509450E-01 |
| N0-vs-N1 |
5.519400E-01 |
|
|
